Germline genetic variants associated with leukocyte-genes predict tumor recurrence in breast cancer patients
J.-S. Milanese, C. Tibiche, J. Zou, Z. G. Meng, A. Nantel, S. Drouin, R. Marcotte, E. Wang
The paper uses germline genetic variants from exome sequencing data to predict tumor recurrence in ER+ breast cancer patients, finding gene signatures associated with recurrence and immune-related pathways.
bioRxiv · Feb 1, 2019Cancer Biology